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in the scientific community focuses on the over‑
rated importance of the IF for research funders 
to judge the quality of research and for universi‑
ties to evaluate the quality of an individual publi‑
cation or researcher. Despite numerous flaws as‑
cribed to a journal’s IF, this measure of a journal’s 
The newest Journal Citation Report (JCR), re‑
leased on June 14, 2017, features 11 459 journals 
in 236 disciplines from 81 countries. A total of 
132 journals received their first impact factor (IF) 
in 2017. A year ‑over ‑year increase in the IF val‑
ues has been reported for 66% of journals, while 
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TABLE 1 Impact factors of Polish biomedical journals (source: Web of Science, June 22, 2017)
Journal IF2016 IF2015
Journal of Physiology and Pharmacology ↑ 2.883 2.804
Pharmacological Reports ↑ 2.587 2.251
Polish Archives of Internal Medicine ↑ 2.191 2.054
Archivum Immunologiae et Therapiae Experimentalis ↓ 2.040 2.464
Archives of Medical Science ↑ 1.969 1.812
Postępy Dermatologii i Alergologii ↑ 1.683 1.342
Journal of Applied Genetics ↓ 1.655 1.929
Hereditary Cancer in Clinical Practice ↑ 1.590 1.550
Journal of Contemporary Brachytherapy ↑ 1.496 1.413
Advances in Medical Sciences ↑ 1.364 1.211
Endokrynologia Polska ↑ 1.341 1.112
Kardiologia Polska ↑ 1.341 0.878
Cardiology Journal ↑ 1.256 1.130
Annals of Transplantation ↑ 1.252 1.032
Acta Neurobiologiae Experimentalis ↓ 1.207 1.708
Advances in Clinical and Experimental Medicine ↑ 1.179 1.127
Acta Parasitologica ↓ 1.160 1.293
Folia Neuropathologica ↓ 1.093 1.233
Psychiatria Polska ↑ 1.010 0.884
Translational Neuroscience ↓ 0.922 1.012
Postępy w Kardiologii Interwencyjnej ↑ 0.917 0.358
Neurologia i Neurochirurgia Polska ↑ 0.857 0.747
Central European Journal of Immunology ↑ 0.776 0.309
Postępy Higieny i Medycyny Doświadczalnej ↓ 0.690 0.769
Ginekologia Polska ↓ 0.576 0.609
Videosurgery and Other Miniinvasive Techniques ↓ 0.493 0.920
Folia Morphologica ↓ 0.341 0.469
Open Medicine 0.294 –
Central European Journal of Medicine ↓ 0.116 0.309
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several original and review papers covering broad 
topics across the spectrum of internal diseases; 
the most highly cited articles in 2016 that were 
published in the years 2014 and 2015 are listed 
in TABLE 2 (original papers) and TABLE 3 (reviews).
On behalf of the Polish Society of Internists, 
I am indebted to the authors who sent us excellent 
reviews and original articles, readers who have cit‑
ed our papers, and executive members of the Sci‑
entific Board, who have supported us. Above all, 
I would like to express my sincere thanks to my 
closest collaborator, Vice ‑Editor ‑in ‑Chief Pro‑
fessor Grzegorz Gajos, and the editorial team, 
Małgorzata Wiesner and Weronika Kużdżał, for 
their hard work. We will try our best to hopeful‑
ly increase the IF and to make the Pol Arch Intern 
Med a world ‑level journal. Thank you for your 
continuous support.
position among other periodicals is significant in 
terms of increasing the credibility of the journal.
The  2016 IF for Pol Arch Intern Med (for‑
merly Pol Arch Med Wewn) has increased to 
2.191. However, since there was a discrepancy be‑
tween our estimated denominator and the final 
denominator shown by the JCR, we decided to 
report this to Thomson Reuters and ask for feed‑
back. In response, we were informed that indeed 
an error had occurred and the number of citable 
items has now been adjusted. The projected new 
IF is 2.309, and a JCR update with new metrics 
will be released in September.
The journal impact factor is the ratio of the last 
year’s citations to articles published in that jour‑
nal in the 2 previous years. Journals with high‑
er IFs are considered to be more influential than 
those with lower ones. Among Polish biomedi‑
cal journals, our standing is solid as reflected in 
the list presented in TABLE 1.
The largest contribution to the 2016 IF of 
the Pol Arch Intern Med has been provided by 
TABLE 2 Most cited original papers contributing to IF2016 (source: Web of Science, June 22, 2017)
No. Paper Citation count 
in 2016 (total 
citation count)
1 Bioresorbable vascular scaffolds in patients with acute coronary syndromes: 
the POLAR ACS study. Dudek D, Rzeszutko Ł, Zasada W, et al. Pol Arch Med Wewn. 
2014; 124: 669-677.
18 (29)
2 Effect of vitamin K -2 on progression of atherosclerosis and vascular calcification  
in nondialyzed patients with chronic kidney disease stages 3–5. Kurnatowska I,  
Grzelak P, Masajtis ‑Zagajewska A, et al. Pol Arch Med Wewn. 2015; 125: 631‑640.
7 (12)
3 General population reference values for 3 ‑level EQ ‑5D (EQ ‑5D ‑3L) questionnaire  
in Poland. Golicki D, Niewada M. Pol Arch Med Wewn. 2015; 125: 18‑26.
7 (10)
4 Usefulness of different ultrasound features of malignancy in predicting the type of 
thyroid lesions: a meta ‑analysis of prospective studies. Wolinski K, Szkudlarek M, 
Szczepanek ‑Parulska E, et al. Pol Arch Med Wewn. 2014; 124: 97‑104.
6 (9)
5 Comparison of conventional and ultrasound -guided needle biopsy techniques in 
the diagnosis of sarcoidosis: a randomized trial. Gnass M, Szlubowski A, Soja J,  
et al. Pol Arch Med Wewn. 2015; 125: 321‑328.
6 (8)
TABLE 3 Most cited review papers contributing to IF2016 (source: Web of Science, June 22, 2017)
No. Paper Citation count 
in 2016 (total 
citation count)
1 Practical aspects of new oral anticoagulant use in atrial fibrillation. Undas A,  
Pasierski T, Windyga J, Crowther M. Pol Arch Med Wewn. 2014; 124: 124‑135.
13 (27)
2 Genetic risk factors of atherothrombosis. Montagnana M, Danese E, Lippi G.  
Pol Arch Med Wewn. 2014; 124: 474‑482.
9 (15)
3 New advances in stem cell research: practical implications for regenerative medicine. 
Ratajczak MZ, Jadczyk T, Pedziwiatr D, et al. Pol Arch Med Wewn. 2014; 124:  
417-426.
8 (17)
4 Drink your prevention: beverages with cancer preventive phytochemicals. Rossi T, 
Gallo C, Bassani B, et al. Pol Arch Med Wewn. 2014; 124: 713‑722.
8 (12)
5 Prevention of ischemic stroke in clinical practice: a role of internists and general 
practitioners. Niewada M, Członkowska A. Pol Arch Med Wewn. 
2014; 124: 540-548.
6 (11)
6 The biomarker paradigm: between diagnostic efficiency and clinical efficacy.  
Lippi G, Mattiuzzi C. Pol Arch Med Wewn. 2015; 125: 282‑288.
6 (11)
7 How to predict and diagnose postthrombotic syndrome. Rabinovich A, Kahn SR.  
Pol Arch Med Wewn. 2014; 124: 410‑416. 
6 (7)
